Martin Hoenigl

发表

An update on current and novel molecular diagnostics for the diagnosis of invasive fungal infections

J. Jenks, P. L. White, P. L. White, 2023, Expert review of molecular diagnostics.

Social determinants of health as drivers of fungal disease

D. Kontoyiannis, S. Wurster, J. Prattes, 2023, EClinicalMedicine.

Universal Digital High Resolution Melt for the detection of pulmonary mold infections

S. I. Fraley, J. Jenks, P. L. White, 2023, bioRxiv.

Performance of existing definitions and tests for the diagnosis of invasive aspergillosis in critically ill, adult patients: a systematic review with qualitative evidence synthesis.

M. Bassetti, E. Righi, F. Taccone, 2020, The Journal of infection.

A conceptual framework for nomenclatural stability and validity of medically important fungi: a proposed global consensus guideline for fungal name changes supported by ABP, ASM, CLSI, ECMM, ESCMID-EFISG, EUCAST-AFST, FDLC, IDSA, ISHAM, MMSA, and MSGERC

T. Dingle, P. Luethy, V. Hubka, 2023, Journal of clinical microbiology.

Integrating genetic and immune factors to uncover pathogenetic mechanisms of viral-associated pulmonary aspergillosis

S. Feys, S. Gonçalves, F. L. van de Veerdonk, 2024, mBio.

COVID-19 associated Pulmonary Aspergillosis in Patients Admitted to the Intensive Care Unit: Impact of Antifungal Prophylaxis

A. Reisinger, J. Prattes, Jonas Frost, 2024, Mycopathologia.

Global guideline for the diagnosis and management of cryptococcosis: an initiative of the ECMM and ISHAM in cooperation with the ASM.

D. Boulware, N. Govender, A. Warris, 2024, The Lancet. Infectious diseases.

New treatment options for critically important WHO fungal priority pathogens.

Johannes Boyer, Lisa Kriegl, Martin Hoenigl, 2024, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Therapeutic drug monitoring of antifungal therapies: do we really need it and what are the best practices?

Johannes Boyer, Lisa Kriegl, Martin Hoenigl, 2024, Expert review of clinical pharmacology.

Scedosporiosis and lomentosporiosis: modern perspectives on these difficult-to-treat rare mold infections

C. Neoh, C. Halliday, S. Y. Tio, 2024, Clinical microbiology reviews.

Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022

A. Barać, Gina Varricchio, G. Nadali, 2024, EClinicalMedicine.

Comparative Analysis of the Clarus Aspergillus Galactomannan Enzyme Immunoassay Prototype for the Diagnosis of Invasive Pulmonary Aspergillosis in Bronchoalveolar Lavage Fluid

J. Prattes, F. Prüller, Johannes Boyer, 2024, Mycopathologia.

Performance of the clarus Aspergillus galactomannan enzyme immunoassay prototype for the diagnosis of invasive pulmonary aspergillosis in serum

F. Prüller, Johannes Boyer, Lisa Kriegl, 2024, Mycoses.

Antifungals in Patients With Extracorporeal Membrane Oxygenation: Clinical Implications

G. Schilcher, I. Zollner-Schwetz, Johannes Boyer, 2024, Open forum infectious diseases.

Exploring European Consensus About the Remaining Treatment Challenges and Subsequent Opportunities to Improve the Management of Invasive Fungal Infection (IFI) in the Intensive Care Unit

Martin Hoenigl, David A Enoch, Dominic Wichmann, 2024, Mycopathologia.

Universal digital high-resolution melting for the detection of pulmonary mold infections

P. L. White, Martin Hoenigl, Sanjay R. Mehta, 2024, Journal of clinical microbiology.

Novel antifungals and treatment approaches to tackle resistance and improve outcomes of invasive fungal disease

M. Arendrup, T. Chiller, S. Feys, 2024, Clinical microbiology reviews.

Circulatory Inflammatory Proteins as Early Diagnostic Biomarkers for Invasive Aspergillosis in Patients with Hematologic Malignancies—an Exploratory Study

I. Ricaño-Ponce, Diletta Rosati, T. Mercier, 2024, Mycopathologia.

Risk of COVID-19-associated pulmonary aspergillosis: time for a nuanced approach to antifungal prophylaxis?

J. Prattes, Martin Hoenigl, 2024, The Lancet. Respiratory medicine.

COVID-19-associated pulmonary aspergillosis in mechanically ventilated patients: a deadly complication

C. Kosmidis, Martin Hoenigl, 2023, Thorax.

Early attainment of isavuconazole target concentration using an increased loading dose in critically ill patients with extracorporeal membrane oxygenation.

A. Meinitzer, G. Schilcher, A. Reisinger, 2023, The Journal of antimicrobial chemotherapy.

Fungal Respiratory Colonization and Infections in Cystic Fibrosis Patients in the Middle East

Sanaz Yaalimadad, M. Ghazanfari, Bahador Nikoueian Shirvan, 2024, Current Fungal Infection Reports.

Breaking the mould: challenging the status quo of clinical trial response definitions for invasive fungal diseases-a debate.

Johan Maertens, Martin Hoenigl, George R. Thompson, 2024, The Journal of antimicrobial chemotherapy.

Attributable mortality of candidemia - Results from the ECMM Candida III multinational European Observational Cohort Study.

A. Barać, A. Azap, D. Giacobbe, 2024, The Journal of infection.

COVID-19 Associated Pulmonary Aspergillosis isolates are genomically diverse but similar to each other in their responses to infection-relevant stresses

Jacob L. Steenwyk, A. Rokas, J. Steenwyk, 2022, bioRxiv.

Epidemiology of Invasive Candidiasis

George R. Thompson III, Martin Hoenigl, Luis Ostrosky-Zeichner, 2024, Clinical epidemiology.